We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Switzerland, China to Harmonize Drug Oversight Activities
Switzerland, China to Harmonize Drug Oversight Activities
Swiss and Chinese regulators plan to harmonize their regulations on market authorization and postmarket surveillance, with the aim of speeding access to new products in both markets.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor